LEXX stock has a bullish outlook with a price target of $7, as maintained by HC Wainwright & Co. on January 24, 2025. This represents a significant upside of over 300% from its current price of $1.77, driven by strong buy ratings and the company's innovative DehydraTECH™ technology. However, recent securities offerings at $3.06 per share may dilute short-term gains but support long-term growth.